Concepedia

Immunotherapy Dose Modification

Immunotherapy Dose Modification is a clinical methodology involving the systematic adjustment of immunotherapeutic agent dosages in response to hepatic function alterations to optimize therapeutic efficacy and minimize hepatotoxicity.

57

Publications

7.8K

Citations

536

Authors

251

Institutions

Publications per year

2017–2026

30

Parents

Publications

57

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry, Bruno Sangro, Thomas Yau et al. · The Lancet · 2017 · 4.3K citations · Full text

, , +13

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

Jeong Heo, Tony Reid, Leyo Ruo et al. · Nature Medicine · 2013 · 776 citations · Full text

, , +16

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

Ahmed O. Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 256 citations · Full text

, , +15

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

Vijay Patil, Vanita Noronha, Nandini Menon et al. · Journal of Clinical Oncology · 2022 · 206 citations

, , +7

Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy

Bronwen R. Burton, Graham J. Britton, Hai Fang et al. · Nature Communications · 2014 · 184 citations · Full text

, , +16

1–5 of 57

Authors

536

  1. SS
    Sakura Sato

    National Sagamihara Hospital, Japan

    3 publications · 166 citations

    3

    h-index

  2. AO
    Ahmed O. Kaseb

    The University of Texas MD Anderson Cancer Center, United States

    3 publications · 348 citations

    3

    h-index

  3. KO
    Kiyotake Ogura

    National Sagamihara Hospital, Japan

    3 publications · 166 citations

    3

    h-index

  4. ME
    Motohiro Ebisawa

    National Sagamihara Hospital, Japan

    3 publications · 166 citations

    3

    h-index

  5. NY
    Noriyuki Yanagida

    National Sagamihara Hospital, Japan

    3 publications · 166 citations

    3

    h-index

1–5 of 536

Institutions

251

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    4 h-index

    50 publications

    7.9K citations

  2. The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, China

    3 h-index

    11 publications

    313 citations

  3. University of California San Diego

    San Diego, United States

    3 h-index

    4 publications

    1.6K citations

  4. National Sagamihara Hospital

    Zama, Japan

    3 h-index

    18 publications

    876 citations

  5. Sun Yat-sen University

    Guangzhou, China

    3 h-index

    11 publications

    313 citations

  6. Yonsei University

    Seoul, South Korea

    2 h-index

    8 publications

    937 citations

  7. Columbia University

    New York, United States

    2 h-index

    2 publications

    45 citations

  8. Harvard University

    Cambridge, United States

    2 h-index

    4 publications

    123 citations

1–8 of 251

Venues

  1. Journal of Clinical Oncology

    8 publications · 502 citations

    8

    h-index

  2. Annals of Allergy Asthma & Immunology

    ACAAI · 4 publications · 139 citations

    4

    h-index

  3. 3

    h-index

  4. Annals of Oncology

    2 publications · 43 citations

    2

    h-index

  5. ˜The œLancet. Gastroenterology & hepatology

    2 publications · 393 citations

    2

    h-index

1–5